DLL3 is an emerging target in SCLC (Morgensztern et al, 2019; Hipp et al, 2020) and it will be interesting in the near future to understand whether targeting this molecule can help block the formation of new metastases or slow the growth of established ones. Here, DLL3 is linked to small cell lung carcinoma.